Formulary

Anti-Cellulite Body Lotion

Released by Evonik Corporation - Personal Care business line

January 1, 2011


Phase A
Tego Care LTP (Evonik) (Sorbitan laurate; polyglyceryl- 4 laurate; dilauryl citrate)
1.50
Tegosoft CI (Evonik) (Cetearyl isononanoate)
10.00
Tegosoft DEC (Evonik) (Diethylhexyl carbonate)
3.50
Tegosoft OP (Evonik) (Ethylhexyl palmitate)
1.10
Tego Xymenynic (Evonik) (Caprylic/capric triglyceride; xymenynic acid (proposed))
2.00
Tego Carbomer 140 (Evonik)
0.15
Tego Carbomer 141 (Evonik)
0.15
Xanthan gum
0.10
Glycerin
3.00
Water
77.50

Phase B
Caffeine
1.00

Phase C
Sodium hydroxide (10% in water)
q.s.

Phase Z
Preservative, perfume
q.s.

Procedure
Mix ingredients of phase A. Combine phases A and B without stirring. Homogenize. Add phases C and Z and stir well.

More Information
Evonik Goldschmidt GmbH, Tel: +49 201 173-2854; Fax: +49 201 173-1828u2028; Email: personal-care@evonik.com; Website: www.evonik.com/personal-care

Related End-User Markets:

blog comments powered by Disqus
  • Take Notice

    Take Notice

    Melissa Meisel , Associate Editor||June 1, 2016
    Packaging trends revolve around trendy artwork, eco-conscious materials—and portability is a plus too!

  • Virtual Reality

    Virtual Reality

    Christine Esposito, Associate Editor||June 1, 2016
    An update on nature-identical ingredients for cosmetics and personal care products.

  • Shiseido Advances in the US

    Shiseido Advances in the US

    Tom Branna, Editorial Director||June 1, 2016
    New facility in Windsor, NJ demonstrates its dedication to the US and other markets outside Japan.